- Home
- Publications
- Publication Search
- Publication Details
Title
NF-κB as a potential therapeutic target in microbial diseases
Authors
Keywords
-
Journal
Molecular BioSystems
Volume 8, Issue 4, Pages 1108
Publisher
Royal Society of Chemistry (RSC)
Online
2012-02-06
DOI
10.1039/c2mb05335g
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proteases of Porphyromonas gingivalis as Important Virulence Factors in Periodontal Disease and Potential Targets for Plant-Derived Compounds: A Review Article
- (2012) Daniel Grenier et al. CURRENT DRUG TARGETS
- Hepatitis B virus X protein enhances NFκB activity through cooperating with VBP1
- (2011) Sang-Yong Kim et al. BMB Reports
- Novel IκB kinase inhibitors for treatment of nuclear factor-κB-related diseases
- (2011) Jun-Ichi Suzuki et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Crosstalk in NF-κB signaling pathways
- (2011) Andrea Oeckinghaus et al. NATURE IMMUNOLOGY
- Inflammation meets cancer, with NF-κB as the matchmaker
- (2011) Yinon Ben-Neriah et al. NATURE IMMUNOLOGY
- Modulation of NF-κB signalling by microbial pathogens
- (2011) Masmudur M. Rahman et al. NATURE REVIEWS MICROBIOLOGY
- Nuclear factor-κB p50 subunits in chronic periodontitis and Porphyromonas gingivalis lipopolysaccharide-pulsed dendritic cells
- (2010) Ravi Jotwani et al. Annals of the New York Academy of Sciences
- NF-κB and innate immunity in ischemic stroke
- (2010) Olivier A. Harari et al. Annals of the New York Academy of Sciences
- Inflammation as “common soil” of the multifactorial diseases
- (2010) Rossana Scrivo et al. AUTOIMMUNITY REVIEWS
- Molecular Mechanisms of System Control of NF-κB Signaling by IκBα
- (2010) Diego U. Ferreiro et al. BIOCHEMISTRY
- Inhibiting NF-κB activation by small molecules as a therapeutic strategy
- (2010) Subash C. Gupta et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Drugs in Development for Influenza
- (2010) David A. Boltz et al. DRUGS
- Lipopolysaccharide-induced activation of NF-κB non-canonical pathway requires BCL10 serine 138 and NIK phosphorylations
- (2010) Sumit Bhattacharyya et al. EXPERIMENTAL CELL RESEARCH
- Viral Fusion Peptides Induce Several Signal Transduction Pathway Activations That Are Essential for Interleukin-10 and Beta-Interferon Production
- (2010) Mariateresa Vitiello et al. INTERVIROLOGY
- Inhibition of active HIV-1 replication by NF-κB inhibitor DHMEQ
- (2010) Ariko Miyake et al. MICROBES AND INFECTION
- Conference Scene: Nanoneuroprotection and nanoneurotoxicity: recent progress and future perspectives
- (2010) Hari Shanker Sharma et al. Nanomedicine
- NF-κB signaling modulation by EBV and KSHV
- (2010) Deilson Elgui de Oliveira et al. TRENDS IN MICROBIOLOGY
- NF-κB/Rel: agonist and antagonist roles in HIV-1 latency
- (2010) Jonathan KL Chan et al. Current Opinion in HIV and AIDS
- HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: microbial interactions in HIV infection
- (2009) Howard CH Yim et al. AIDS
- Inhibition of Transcription Factors by Plant-Derived Compounds and their Implications in Inflammation and Cancer
- (2009) J. Rios et al. CURRENT PHARMACEUTICAL DESIGN
- Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy
- (2009) S. Ludwig JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hepatitis B Virus X Protein Modulates Apoptosis in Primary Rat Hepatocytes by Regulating both NF- B and the Mitochondrial Permeability Transition Pore
- (2009) A. J. Clippinger et al. JOURNAL OF VIROLOGY
- Oligonucleotide decoy to NF-κB slowly released from PLGA microspheres reduces chronic inflammation in rat
- (2009) Daniela De Stefano et al. PHARMACOLOGICAL RESEARCH
- Potential pharmacological control of the NF-κB pathway
- (2009) Gautam Sethi et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Identification of the RelA domain responsible for action of a new NF-κB inhibitor DHMEQ
- (2008) Mariko Watanabe et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Denbinobin, a naturally occurring 1,4-phenanthrenequinone, inhibits HIV-1 replication through an NF-κB-dependent pathway
- (2008) Gonzalo Sánchez-Duffhues et al. BIOCHEMICAL PHARMACOLOGY
- Shared Principles in NF-κB Signaling
- (2008) Matthew S. Hayden et al. CELL
- Role of Protein Tyrosine Kinase and Erk1/2 Activities in the Toll-Like Receptor 2-Induced Cellular Activation of Murine B Cells by Neisserial Porin
- (2008) H. MacLeod et al. Clinical and Vaccine Immunology
- The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis
- (2008) George D Kalliolias et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Hepatitis C Virus (HCV): A Review of Immunological Aspects
- (2008) M. Irshad et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- NF-κB in liver diseases: a target for drug therapy
- (2008) Pablo Muriel JOURNAL OF APPLIED TOXICOLOGY
- HTLV-1 Tax-induced NF-κB activation is synergistically enhanced by 12-O-tetradecanoylphorbol-13-acetate: mechanism and implications for Tax oncogenicity
- (2008) Inbal Azran-Shaish et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- NF- B Signaling Differentially Regulates Influenza Virus RNA Synthesis
- (2008) N. Kumar et al. JOURNAL OF VIROLOGY
- NF-κB signaling, liver disease and hepatoprotective agents
- (2008) B Sun et al. ONCOGENE
- Influenza A Virus Inhibits Type I IFN Signaling via NF-κB-Dependent Induction of SOCS-3 Expression
- (2008) Eva-K. Pauli et al. PLoS Pathogens
- Macrophage activation by endogenous danger signals
- (2007) X Zhang et al. JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now